Precision medicine is revolutionizing healthcare by tailoring medical treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors. The integration of big data, bioinformatics, and AI technologies is enabling healthcare providers to predict disease risks, personalize treatment plans, and improve patient outcomes. This approach moves beyond the traditional "one size fits all" medical approach, incorporating advanced data analytics and genomic insights to provide more effective and personalized care.
Report Scope
- Precision medicine is advancing diagnostics.
- Recent advancements in precision medicine are particularly evident in oncology.
- The precision medicine landscape is shaped by macroeconomic and regulatory trends.
Reasons to Buy
- Understand the major players in the precision medicine space, as well as the future of the theme.
- Learn about the different technology, macro, and regulatory trends impacting precision medicine.
- Learn about industry growth and the key advancements in precision medicine.
Table of Contents
- Executive Summary
- Players
- Technology Briefing
- Trends
- Industry Analysis
- Value Chain
- Companies
- Sector Scorecards
- Glossary
- Further Reading
- Thematic Research Methodology
- About the Analyst
- Contact the Publisher
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Tempus AI
- Illumina
- Roche
- 10x Genomics
- Siemens
- Thermo Fisher Scientific
- Materialise
- Stryker
- Danaher
- Sophia Genetics
- Guardant Health
